Skip to main content
HARBIN GLORIA PHARMACEUTICALS Co., LTD logo

HARBIN GLORIA PHARMACEUTICALS Co., LTD — Investor Relations & Filings

Ticker · 002437 ISIN · CNE100000QG8 LEI · 300300K1ZDAXM6M73U33 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,133 across all filing types
Latest filing 2022-11-11 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002437

About HARBIN GLORIA PHARMACEUTICALS Co., LTD

https://www.gloria.cc

Harbin Gloria Pharmaceuticals Co., Ltd. focuses on the research, development, manufacturing, and commercialization of diverse pharmaceutical products. The company specializes in therapeutic areas including cardiovascular and cerebrovascular diseases, orthopedics, oncology, and metabolic disorders. Its portfolio comprises chemical drugs, biological products, and specialized injections, with key products such as Alprostadil and Deer Melon Polypeptide. The organization prioritizes technological innovation through a dedicated R&D infrastructure aimed at developing both generic and innovative medications. It maintains multiple production facilities and an extensive distribution network to supply healthcare solutions for chronic and acute conditions.

Recent filings

Filing Released Lang Actions
关于选举第六届监事会职工代表监事的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of a new employee representative supervisor to the company's supervisory board. It includes details about the election process, the candidate's qualifications, and compliance with relevant laws and regulations. There is no financial data, no discussion of financial results, no mention of annual or interim reports, and no indication of a shareholder vote result announcement. The content focuses on board/management information, specifically about changes in the supervisory board composition. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or a certification, so it is not RPA or RNS. Confidence is high due to clear content and context.
2022-11-11 Chinese
关于全资子公司出售闲置房产的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from Harbin Yuheng Pharmaceutical Co., Ltd. regarding the progress of a transaction involving the sale and subsequent lease of idle property by its wholly-owned subsidiary. It details the termination of a sale contract and the initiation of a lease agreement, including financial terms and impact on the company. The document is short (1131 characters) and focuses on a specific transaction update rather than comprehensive financial data or report. It does not contain financial statements or detailed financial performance data. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including asset sales or leases.
2022-10-28 Chinese
关于股东可能减持公司股票计划期限届满的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from Harbin Yuheng Pharmaceutical Co., Ltd. regarding the expiration of a shareholder stock reduction plan period. It details that the shareholders YU HENG INTERNATIONAL INVESTMENTS CORPORATION and ORIENTAL KEYSTONE INVESTMENT LIMITED did not reduce their shares during the plan period. The document includes specific shareholding data before and after the plan period and confirms compliance with relevant securities regulations. There is no financial report, earnings data, or management discussion. The document is a formal disclosure about shareholder shareholding changes and compliance with regulatory requirements related to share reduction plans. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes or plans related to significant share ownership levels and shareholder actions affecting shareholding.
2022-10-27 Chinese
独立董事候选人声明（薛挥）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of Harbin Yuheng Pharmaceutical Co., Ltd. It contains detailed statements about the candidate's qualifications, compliance with relevant laws and regulations, and independence criteria. There are no financial statements, earnings data, or report summaries. The content focuses on governance and compliance related to board membership qualifications. This type of document fits best under Board/Management Information (MANG), as it announces and confirms information about a board candidate's eligibility and independence.
2022-10-26 Chinese
独立董事候选人声明（杨华蓉）
Board/Management Information Classification · 95% confidence The document is a formal statement by an independent director candidate of Harbin Yuheng Pharmaceutical Co., Ltd. It contains detailed declarations about the candidate's qualifications, compliance with relevant laws and regulations, and independence criteria. There are no financial statements, earnings data, or report summaries. The content focuses on the candidate's eligibility and compliance for a board position, which aligns with announcements related to board or management information. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is about 5,047 characters, which is sufficient for a detailed declaration but not a full report or announcement of a report publication.
2022-10-26 Chinese
独立董事候选人声明（董琦）
Board/Management Information Classification · 95% confidence The document is a detailed declaration by an independent director candidate of Harbin Yuheng Pharmaceutical Co., Ltd. It contains statements about the candidate's qualifications, compliance with various regulatory requirements, and independence criteria. There are no financial statements, earnings data, or report summaries. The content focuses on governance and compliance related to board membership qualifications. This fits the category of Board/Management Information (MANG), as it announces and confirms the status and qualifications of a board candidate rather than financial or operational reports.
2022-10-26 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.